HCA Healthcare, Inc. $HCA Shares Sold by Swiss National Bank

Swiss National Bank trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 13.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 448,840 shares of the company’s stock after selling 71,260 shares during the quarter. Swiss National Bank’s holdings in HCA Healthcare were worth $209,545,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in HCA. Nordea Investment Management AB increased its position in HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after acquiring an additional 108,849 shares during the period. Hudson Bay Capital Management LP increased its position in HCA Healthcare by 154.5% in the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock valued at $2,000,000 after acquiring an additional 2,849 shares during the period. Nomura Asset Management Co. Ltd. increased its position in HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after acquiring an additional 3,724 shares during the period. Advisors Capital Management LLC boosted its stake in HCA Healthcare by 61.5% during the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after purchasing an additional 2,604 shares in the last quarter. Finally, CWA Asset Management Group LLC boosted its stake in HCA Healthcare by 1,062.4% during the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock valued at $4,461,000 after purchasing an additional 8,733 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have issued reports on HCA shares. JPMorgan Chase & Co. decreased their price target on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. Stephens decreased their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. UBS Group increased their price target on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research note on Monday, February 23rd. Finally, Argus reduced their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $506.14.

HCA Healthcare Stock Up 1.2%

HCA opened at $377.81 on Friday. The firm has a market cap of $83.81 billion, a PE ratio of 12.99, a P/E/G ratio of 1.18 and a beta of 1.12. The business has a fifty day simple moving average of $431.36 and a 200-day simple moving average of $474.09. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s revenue was up 4.3% compared to the same quarter last year. During the same period in the prior year, the business earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.